The WHO pointers stipulate that manufacturers have to build and adhere to in-depth maintenance schedules depending on equipment requirements and use patterns. Manufacturers seeking to carry out these methods will have to present sturdy validation data to show their equivalence to pharmacopoeial procedures. As these new technologies emerge